Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.

The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen into s.c. lymph nodes. The objective was to evaluate safety and efficacy compared with conventional s.c. immunotherapy. In a monocentric open-label trial, 165 patients with grass pollen-induced rhinoconjunctivitis were randomized to receive either 54 s.c. injections with pollen extract over 3 years [cumulative allergen dose 4,031,540 standardized quality units (SQ-U)] or 3 intralymphatic injections over 2 months (cumulative allergen dose 3,000 SQ-U). Patients were evaluated after 4 months, 1 year, and 3 years by nasal provocation, skin prick testing, IgE measurements, and symptom scores. Three low-dose intralymphatic allergen administrations increased tolerance to nasal provocation with pollen already within 4 months (P < 0.001). Tolerance was long lasting and equivalent to that achievable after standard s.c. immunotherapy (P = 0.291 after 3 years). Intralymphatic immunotherapy ameliorated hay fever symptoms (P < 0.001), reduced skin prick test reactivity (P < 0.001), decreased specific serum IgE (P < 0.001), caused fewer adverse events than s.c. immunotherapy (P = 0.001), enhanced compliance (P < 0.001), and was less painful than venous puncture (P = 0.018). In conclusion, intralymphatic allergen administration enhanced safety and efficacy of immunotherapy and reduced treatment time from 3 years to 8 weeks.

Gender differences in syringe exchange program use in Oslo, Norway.

AIMS: To examine gender differences in syringe exchange program (SEP) use, particularly frequent SEP use, within and across survey years. DESIGN: Three consecutive, anonymous cross-sectional surveys. SETTING: The SEP in Oslo, Norway. PARTICIPANTS: Two hundred and eighty-eight, 449 and 523 SEP participants interviewed during comparable 1-week periods in 1992, 1994 and 1997, respectively. MEASUREMENTS: Brief structured questionnaires assessed SEP use, HIV risk behaviors and self-reported HIV status. Chi square statistics, t-tests and analysis of variance were used to identify gender differences; logistic regression was used to identify independent correlates of frequent SEP use. FINDINGS: Women reported injecting more frequently than men, but neither reported more frequent SEP use nor acquiring more syringes during an exchange. Although syringe sharing decreased significantly over time, in 1997, 51% of SEP participants continued to share. HIV prevalence remained low (3-5%) over time. After controlling for gender, age and HIV risk factors, frequent SEP use was significantly correlated with frequent injection for both women (OR = 1.4) and men (OR = 1.5). A lack of income or benefits independently increased the likelihood of being a frequent SEP user (OR = 3.0), while having shared a syringe at last injection independently decreased this likelihood (OR = 0.5). CONCLUSIONS: Gender was not associated with frequent SEP use; rather, the single most important correlate of frequent SEP use was injection frequency. Women's need for sterile syringes may not be fully addressed, despite the existence of a well-established and well-utilized SEP.

[The clinical estimate of adiposity is not a good predictor of insulin tissue sensitivity measured with a minimal model analysis]. / La estimación clínica de la adiposidad no es un buen predictor de la sensibilidad tisular a la insulina medida con un analisis de modelo mínimo.

Fifteen male volunteers, aged 30 to 40 years old, were classified according to body mass index (BMI) as lean (n = 5, BMI less than 20 kg/m2), normal (n = 5, BMI 20-25) or obese (n = 5, BMI over 30). Glucose intolerance was ruled out by a normal oral glucose tolerance test and insulin sensitivity (SI) and glucose effectiveness (SG) were estimated by a minimal model analysis of a frequently sampled intravenous glucose tolerance test modified by an intravenous insulin injection at minute 20. The MINMOD program was fed with 29 or 12 values (reduced sampling schedule). Despite a significant inverse correlation between BMI and SI (r = -0.533 p < 0.05), the latter parameter overlapped among groups and the correlation was lost when obese individuals were not considered. Waist/hip ratio correlated modestly with SI (r = -0.52 p < 0.05). SG did not correlate with BMI. Using the reduced sampling schedule. SI values had a correlation coefficient of 0.78 with those calculated using the usual sampling schedule, although they were 82% lower. We conclude that only a BMI of over 30 accurately predicts a low SI, and that waist/hip ratio does not have a better predictive power.

[Insulin resistance: a frequent phenomenon in clinical practice]. / Insulinorresistencia, un fenómeno frecuente en clínica.

This review is focused on the diagnostic, clinical and therapeutic aspects of insulin resistance relevant to the clinician. The observed phenomenon of the wide variability of insulin sensitivity in clinically healthy subjects is discussed; qualitative and quantitative aspects of the methodologies currently used for the assessment of insulin sensitivity in the clinical setting are dealt with, as well as their applicability to day-to-day clinical care. The medical consequences of hyperinsulinemia, including dyslipidemia, hypertension coronary artery disease and ovarian hyperandrogenism are likewise discussed. A panoramic view of the various clinical presentations of insulin resistance is also offered, including clinical elements for suspicion, as well as an account of the prevalent, less-prevalent and rare disorders harboring the phenomenon of insulin resistance. The final topic of the review is a novel discussion on the therapeutic possibilities in insulin resistance disorders, including treatment with hormones and antihormones.

[Diabetic papillopathy. Report of a case]. / Papilopatía diabética. Caso clínico.

A 17-year-old patient with long-standing poorly controlled type I diabetes mellitus developed bilateral transient edema of the optic disc with minimal visual impairment. Evaluation with fluoresceins angiography revealed the typical pattern of diabetic papillopathy with disc swelling and peripapillary capillary dilatation. Complete resolution occurred within 6 months, with no specific therapy other than improvement of metabolic control with insulin therapy. Early diagnosis of this complication is required to avoid ocular damage.

[Insulin sensitivity: absence of sexual differences when expressed as a function of lean body mass]. / Sensibilidad a la insulina: ausencia de diferencias, sexuales al expresarla en función de la masa magra.

The hyperinsulinemic, euglycemic clamp technique was used to test the hypothesis that--when expressed per kilogram of lean body mass--there is a sex-difference in peripheral insulin-mediated glucose disposal (M), as proposed in the literature. Lean body mass was assessed with tetrapolar bioelectric impedance analysis. We studied 15 normal subjects (volunteers with normal glucose tolerance and body mass indices between 20-25 kg/m2) of both sexes, 9 women and 6 men, of 2 age-groups, 20-30 year-old and 40-50 year-old. Men and women were similarly aged (33.3 +/- 3.8 and 33.3 +/- 3.8 years, respectively). Body mass indices were similar in both sexes (22.5 +/- 0.6 in women and 23.6 +/- 0.7 in men, NS) but percentages of fat mass were not (29.4 +/- 1.2 in women and 20.6 +/- 1.6 in men, p less than 0.001). As no difference in M (mg of glucose metabolized per kilogram of body weight per minute) between age-groups was found (6.4 +/- 0.8 and 6.8 +/- 1.2 mg/kg/min, NS) the data from these 2 age-groups were pooled. When M values obtained in both sexes were compared no differences were found (7.1 +/- 1.5 mg/kg/min in women and 6.3 +/- 0.6 in men, NS). Similarly, when M was expressed in function of the prevailing insulin levels attained during steady-state, M/l, no differences were disclosed (8.98 +/- 2 mg/kg/min/microIU insulin in women and 7.8 +/- 1.2 in men, NS).(ABSTRACT TRUNCATED AT 250 WORDS)

[Incidence of gestational diabetes in pregnant women at diabetic risk in Santiago, Chile]. / Frecuencia de diabetes gestacional en embarazadas en riesgo diabético de Santiago, Chile.

A study conducted from 1982 to 1984 in Santiago, Chile, examined the frequency of gestational diabetes in 580 pregnant women at high risk for diabetes and 100 controls receiving prenatal checkups at a primary care center in the western area of the city. The purpose of the study was to establish recommendations for early detection in developing countries. The risk factors for the disease were studied and their frequency and distribution were calculated in 911 pregnant women in the general population of the area. The diagnosis of gestational diabetes was based on the results of the oral glucose tolerance test. The disease was diagnosed in 13.8% of the pregnant women with risk factors for diabetes and in 1% of the controls. Three risk factors were statistically significant: chronological age (OR = 1.14), nutritional status (OR = 1.01), and basal blood glucose level (OR, 25-36 years = 4.03; OR, greater than 36 years = 4.84). The prevalence of gestational diabetes was 4.27%. It was concluded that the frequency of gestational diabetes is significantly higher in pregnant women at risk for diabetes than in those not at risk. In developing countries it is recommended that testing for the disease be limited to pregnant women over 25 years of age, those who are obese, and those with a fasting blood glucose level above 4.4 mmol/l.